Receptor type protein tyrosine phosphatases (RPTPs) - Roles in signal transduction and human disease

Journal of Cell Communication and Signaling

Volumn 6, Issue 3, 2012, Pages 125-138

  Xu, Yiru ^a   Fisher, Gary J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cell adhesion; Cell communic; Cell surface receptor; Protein tyrosine phosphorylation; Receptor protein tyrosine phosphatase; Signal Transduction

Indexed keywords

CD45 ANTIGEN; CELL SURFACE RECEPTOR; DENSITY ENHANCED PHOSPHATASE 1; LEUKOCYTE COMMON ANTIGEN RELATED PROTEIN; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN TYROSINE KINASE ALPHA; RECEPTOR PROTEIN TYROSINE KINASE GAMMA; RECEPTOR PROTEIN TYROSINE KINASE KAPPA; SYNDECAN; UNCLASSIFIED DRUG;

CELL ADHESION; CELL COMMUNICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 85027957793     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-012-0171-5     Document Type: Review

References (195)

1. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T (2004) Protein tyrosine phosphatases in the human genome. Cell 117:699-711
2. Anders L, Mertins P, Lammich S, Murgia M, Hartmann D, Saftig P, Haass C, Ullrich A (2006) Furin-, ADAM 10-, and gammasecretase- mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity. Mol Cell Biol 26:3917-3934
3. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Moller NP (2001) Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21:7117-7136
4. Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK, Moller NP (2004) A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J 18:8-30
5. Ardini E, Agresti R, Tagliabue E, Greco M, Aiello P, Yang LT, Menard S, Sap J (2000) Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo. Oncogene 19:4979-4987
6. Ashwell JD, D'Oro U (1999) CD45 and Src-family kinases: and now for something completely different. Immunol Today 20:412-416
7. Autero M, Saharinen J, Pessa-Morikawa T, Soula-Rothhut M, Oetken C, Gassmann M, Bergman M, Alitalo K, Burn P, Gahmberg CG et al (1994) Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase. Mol Cell Biol 14:1308-1321
8. Balavenkatraman KK, Jandt E, Friedrich K, Kautenburger T, Pool- Zobel BL, Ostman A, Bohmer FD (2006) DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene 25:6319-6324
9. Barnea G, Silvennoinen O, Shaanan B, Honegger AM, Canoll PD, D'Eustachio P, Morse B, Levy JB, Laforgia S, Huebner K et al (1993) Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases. Mol Cell Biol 13:1497-1506
10. Beltran PJ, Bixby JL (2003) Receptor protein tyrosine phosphatases as mediators of cellular adhesion. Front Biosci 8:d87-d99
11. Bilwes AM, den Hertog J, Hunter T, Noel JP (1996) Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 382:555-559
12. Blanchetot C, Tertoolen LG, den Hertog J (2002) Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress. EMBO J 21:493-503
13. Blondet B, Carpentier G, Lafdil F, Courty J (2005) Pleiotrophin cellular localization in nerve regeneration after peripheral nerve injury. J Histochem Cytochem 53:971-977
14. Bodrikov V, Leshchyns'ka I, Sytnyk V, Overvoorde J, den Hertog J, Schachner M (2005) RPTPalpha is essential for NCAM-mediated p59fyn activation and neurite elongation. J Cell Biol 168:127-139
15. Boxall S, Stanton T, Hirai K, Ward V, Yasui T, Tahara H, Tamori A, Nishiguchi S, Shiomi S, Ishiko O et al (2004) Disease associations and altered immune function in CD45 138G variant carriers. Hum Mol Genet 13:2377-2384
16. Brady-Kalnay SM, Tonks NK (1994) Identification of the homophilic binding site of the receptor protein tyrosine phosphatase PTP mu. J Biol Chem 269:28472-28477
17. Brady-Kalnay SM, Tonks NK (1995) Protein tyrosine phosphatases as adhesion receptors. Curr Opin Cell Biol 7:650-657
18. Buist A, Zhang YL, Keng YF, Wu L, Zhang ZY, den Hertog J (1999) Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha. Biochemistry 38:914-922
19. Buschbeck M, Eickhoff J, Sommer MN, Ullrich A (2002) Phosphotyrosine- specific phosphatase PTP-SL regulates the ERK5 signaling pathway. J Biol Chem 277:29503-29509
20. Byth KF, Conroy LA, Howlett S, Smith AJ, May J, Alexander DR, Holmes N (1996) CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp Med 183:1707-1718
21. Chagnon MJ, Uetani N, Tremblay ML (2004) Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochem Cell Biol 82:664-675
22. CharbonneauH, TonksNK,WalshKA, Fischer EH (1988) The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc Natl Acad Sci U S A 85:7182-7186
23. Chirivi RG, Dilaver G, van de Vorstenbosch R,Wanschers B, Schepens J, Croes H, Fransen J, HendriksW(2004) Characterization ofmultipletranscripts and isoforms derived from the mouse protein tyrosine phosphatase gene Ptprr. Genes Cells 9:919-933
24. Chirivi RG, Noordman YE, Van der Zee CE, Hendriks WJ (2007) Altered MAP kinase phosphorylation and impaired motor coordination in PTPRR deficient mice. J Neurochem 101:829-840
25. Chow JP, Fujikawa A, Shimizu H, Suzuki R, Noda M (2008) Metalloproteinase- and gamma-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z. J Biol Chem 283:30879-30889
26. Coffey RJ Jr, Bascom CC, Sipes NJ, Graves-Deal R, Weissman BE, Moses HL (1988) Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol Cell Biol 8:3088-3093
27. De Guzman BB, Hisatsune J, Nakayama M, Yahiro K, Wada A, Yamasaki E, Nishi Y, Yamazaki S, Azuma T, Ito Y et al (2005) Cytotoxicity and recognition of receptor-like protein tyrosine phosphatases, RPTPalpha and RPTPbeta, by Helicobacter pylori m2VacA. Cell Microbiol 7:1285-1293
28. den Hertog J (1999) Protein-tyrosine phosphatases in development. Mech Dev 85:3-14
29. den Hertog J, Hunter T (1996) Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains. EMBO J 15:3016-3027
30. den Hertog J, Pals CE, Peppelenbosch MP, Tertoolen LG, de Laat SW, Kruijer W (1993) Receptor protein tyrosine phosphatase alpha activates pp 60c-src and is involved in neuronal differentiation. EMBO J 12:3789-3798
31. den Hertog J, Tracy S, Hunter T (1994) Phosphorylation of receptor protein-tyrosine phosphatase alpha on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein GRB-2 in vivo. EMBO J 13:3020-3032
32. den Hertog J, Sap J, Pals CE, Schlessinger J, Kruijer W (1995) Stimulation of receptor protein-tyrosine phosphatase alpha activity and phosphorylation by phorbol ester. Cell Growth Differ 6:303-307
33. den Hertog J, Blanchetot C, Buist A, Overvoorde J, van der Sar A, Tertoolen LG (1999) Receptor protein-tyrosine phosphatase signalling in development. Int J Dev Biol 43:723-733
34. Desai DM, Sap J, Schlessinger J, Weiss A (1993) Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase. Cell 73:541-554
35. Do HT, BaarsW, Borns K,WindhagenA, Schwinzer R (2006) The 77C->G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis. J Immunol 176:931-938
36. Drosopoulos NE, Walsh FS, Doherty P (1999) A soluble version of the receptor-like protein tyrosine phosphatase kappa stimulates neurite outgrowth via a Grb2/MEK1-dependent signaling cascade. Mol Cell Neurosci 13:441-449
37. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77:916-928
38. Edmonds SD, Ostergaard HL (2002) Dynamic association of CD45 with detergent-insoluble microdomains in T lymphocytes. J Immunol 169:5036-5042
39. Fischer EH, Charbonneau H, Tonks NK (1991) Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253:401-406
40. Flavell JR, Baumforth KR, Wood VH, Davies GL, Wei W, Reynolds GM, Morgan S, Boyce A, Kelly GL, Young LS et al (2008) Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood 111:292-301
41. Fox AN, Zinn K (2005) The heparan sulfate proteoglycan syndecan is an in vivo ligand for the Drosophila LAR receptor tyrosine phosphatase. Curr Biol 15:1701-1711
42. Fuchs M, Muller T, Lerch MM, Ullrich A (1996) Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. J Biol Chem 271:16712-16719
43. Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, Fukada M, Shintani T, Wada A, Aoyama N, Hirayama T et al (2003) Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 33:375-381
44. Fukada M, Kawachi H, Fujikawa A, Noda M (2005) Yeast substratetrapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z. Methods 35:54-63
45. Fukada M, Fujikawa A, Chow JP, Ikematsu S, Sakuma S, Noda M (2006) Protein tyrosine phosphatase receptor type Z is inactivated by ligand-induced oligomerization. FEBS Lett 580:4051-4056
46. Furukawa T, Itoh M, Krueger NX, Streuli M, Saito H (1994) Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine- phosphorylated CD3 zeta chain. Proc Natl Acad Sci U S A 91:10928-10932
47. GebbinkMF, van Etten I, Hateboer G, Suijkerbuijk R, Beijersbergen RL, Geurts van Kessel A, Moolenaar WH (1991) Cloning, expression and chromosomal localization of a new putative receptor-like protein tyrosine phosphatase. FEBS Lett 290:123-130
48. Gebbink MF, Verheijen MH, Zondag GC, van Etten I, Moolenaar WH (1993) Purification and characterization of the cytoplasmic domain of human receptor-like protein tyrosine phosphatase RPTP mu. Biochemistry 32:13516-13522
49. Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO et al (2003) Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 161:793-804
50. Greer SF, Wang Y, Raman C, Justement LB (2001) CD45 function is regulated by an acidic 19-amino acid insert in domain II that serves as a binding and phosphoacceptor site for casein kinase 2. J Immunol 166:7208-7218
51. Guan KL, Dixon JE (1991) Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J Biol Chem 266:17026-17030
52. Harashima S, Clark A, Christie MR, Notkins AL (2005) The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion. Proc Natl Acad Sci U S A 102:8704-8709
53. Harder KW, Saw J, Miki N, Jirik F (1995) Coexisting amplifications of the chromosome 1p32 genes (PTPRF and MYCL1) encoding protein tyrosine phosphatase LAR and L-myc in a small cell lung cancer line. Genomics 27:552-553
54. Harroch S, Furtado GC, Brueck W, Rosenbluth J, Lafaille J, Chao M, Buxbaum JD, Schlessinger J (2002) A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat Genet 32:411-414
55. Heck N, Klausmeyer A, Faissner A, Garwood J (2005) Cortical neurons express PSI, a novel isoform of phosphacan/RPTPbeta. Cell Tissue Res 321:323-333
56. Hendriks WJ, Dilaver G, Noordman YE, Kremer B, Fransen JA (2009) PTPRR protein tyrosine phosphatase isoforms and locomotion of vesicles and mice. Cerebellum 8:80-88
57. Hermiston ML, Xu Z, Weiss A (2003) CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21:107-137
58. Herradon G, Ezquerra L (2009) Blocking receptor protein tyrosine phosphatase beta/zeta: a potential therapeutic strategy for Parkinson's disease. Curr Med Chem 16:3322-3329
59. Hida H, Jung CG, Wu CZ, Kim HJ, Kodama Y, Masuda T, Nishino H (2003) Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. Eur J Neurosci 17:2127-2134
60. Holmes N (2006) CD45: all is not yet crystal clear. Immunology 117:145-155
61. Hu YF, Zhang HL, Cai T, Harashima S, Notkins AL (2005) The IA-2 interactome. Diabetologia 48:2576-2581
62. Hunter T (1987) A thousand and one protein kinases. Cell 50:823-829
63. Hunter T (1995) Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225-236
64. Iervolino A, Iuliano R, Trapasso F, Viglietto G,Melillo RM, Carlomagno F, Santoro M, Fusco A (2006) The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. Cancer Res 66:6280-6287
65. Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, Griffiths E, Krawczyk C, Richardson CD, Aitken K et al (2001) CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409:349-354
66. Irles C, Symons A, Michel F, Bakker TR, van der Merwe PA, Acuto O (2003) CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Nat Immunol 4:189-197
67. Iuliano R, Le Pera I, Cristofaro C, Baudi F, Arturi F, Pallante P, Martelli ML, Trapasso F, Chiariotti L, Fusco A (2004) The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene 23:8432-8438
68. Iuliano R, Raso C, Quintiero A, Pera IL, Pichiorri F, Palumbo T, Palmieri D, Pattarozzi A, Florio T, Viglietto G et al (2009) The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization. J Biochem 145:377-385
69. Jiang YP, Wang H, D'Eustachio P, Musacchio JM, Schlessinger J, Sap J (1993) Cloning and characterization of R-PTP-kappa, a new member of the receptor protein tyrosine phosphatase family with a proteolytically cleaved cellular adhesion molecule-like extracellular region. Mol Cell Biol 13:2942-2951
70. Jiang G, den Hertog J, Su J, Noel J, Sap J, Hunter T (1999) Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatasealpha. Nature 401:606-610
71. Jiang G, den Hertog J, Hunter T (2000) Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface. Mol Cell Biol 20:5917-5929
72. Johnson KG, Tenney AP, Ghose A, Duckworth AM, Higashi ME, Parfitt K, Marcu O, Heslip TR, Marsh JL, Schwarz TL et al (2006) The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development. Neuron 49:517-531
73. Jung CG, Hida H, Nakahira K, Ikenaka K, Kim HJ, Nishino H (2004) Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cellderived nestin-positive cells. FASEB J 18:1237-1239
74. Kaplan R, Morse B, Huebner K, Croce C, Howk R, Ravera M, Ricca G, Jaye M, Schlessinger J (1990) Cloning of three human tyrosine phosphatases reveals a multigene family of receptor-linked protein-tyrosine-phosphatases expressed in brain. Proc Natl Acad Sci U S A 87:7000-7004
75. Katagiri T, Ogimoto M, Hasegawa K, Arimura Y, Mitomo K, Okada M, Clark MR, Mizuno K, Yakura H (1999) CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells. J Immunol 163:1321-1326
76. Kawachi H, Fujikawa A, Maeda N, Noda M (2001) Identification of GIT1/Cat-1 as a substrate molecule of protein tyrosine phosphatase zeta /beta by the yeast substrate-trapping system. Proc Natl Acad Sci U S A 98:6593-6598
77. Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S (1996) The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res 56:4236-4243
78. Kikuchi-Horie K, Kawakami E, Kamata M, Wada M, Hu JG, Nakagawa H, Ohara K,Watabe K, Oyanagi K (2004) Distinctive expression of midkine in the repair period of rat brain during neurogenesis: immunohistochemical and immunoelectron microscopic observations. J Neurosci Res 75:678-687
79. Kong YY, Kishihara K, Yoshida H, Mak TW, Nomoto K (1995) Generation of T cells with differential responses to alloantigens in CD45 exon 6-deficient mice. J Immunol 154:5725-5735
80. Konishi N, Tsujikawa K, Yamamoto H, Ishida E, Nakamura M, Shimada K, Yane K, Yamashita H, Noguchi S (2003) Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas. Br J Cancer 88:1223-1228
81. Kovalenko M, Denner K, Sandstrom J, Persson C, Gross S, Jandt E, Vilella R, Bohmer F, Ostman A (2000) Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J Biol Chem 275:16219-16226
82. Krueger NX, Saito H (1992) A human transmembrane proteintyrosine- phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases. Proc Natl Acad Sci U S A 89:7417-7421
83. Krueger NX, Streuli M, Saito H (1990) Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J 9:3241-3252
84. Kulas DT, Goldstein BJ, Mooney RA (1996) The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases. J Biol Chem 271:748-754
85. Kung C, Pingel JT, Heikinheimo M, Klemola T, Varkila K, Yoo LI, Vuopala K, Poyhonen M, Uhari M, Rogers M et al (2000) Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 6:343-345
86. Kypta RM, Su H, Reichardt LF (1996) Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex. J Cell Biol 134:1519-1529
87. Lammers R, Lerch MM, Ullrich A (2000) The carboxyl-terminal tyrosine residue of protein-tyrosine phosphatase alpha mediates association with focal adhesion plaques. J Biol Chem 275:3391- 3396
88. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E (2006) Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 174:593-604
89. Lan MS, Lu J, Goto Y, Notkins AL (1994) Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA- 2, from human insulinoma. DNA Cell Biol 13:505-514
90. Lan MS, Wasserfall C, Maclaren NK, Notkins AL (1996) IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 93:6367-6370
91. Le HT, Ponniah S, Pallen CJ (2004) Insulin signaling and glucose homeostasis in mice lacking protein tyrosine phosphatase alpha. Biochem Biophys Res Commun 314:321-329
92. Lee JM, Fournel M, Veillette A, Branton PE (1996) Association of CD45 with Lck and components of the Ras signalling pathway in pervanadate-treated mouse T-cell lines. Oncogene 12:253-263
93. Levea CM, McGary CT, Symons JR, Mooney RA (2000) PTP LAR expression compared to prognostic indices in metastatic and nonmetastatic breast cancer. Breast Cancer Res Treat 64:221-228
94. Lim KL, Kolatkar PR, Ng KP, Ng CH, Pallen CJ (1998) Interconversion of the kinetic identities of the tandem catalytic domains of receptor-like protein-tyrosine phosphatase PTPalpha by two point mutations is synergistic and substrate-dependent. J Biol Chem 273:28986-28993
95. Lynch KW, Weiss A (2001) A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J Biol Chem 276:24341-24347
96. Maeda N, Noda M (1998) Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin- binding growth-associated molecule (HB-GAM) in neuronal migration. J Cell Biol 142:203-216
97. Maeda N, Hamanaka H, Shintani T, Nishiwaki T, Noda M (1994) Multiple receptor-like protein tyrosine phosphatases in the form of chondroitin sulfate proteoglycan. FEBS Lett 354:67-70
98. Maeda N, Ichihara-Tanaka K, Kimura T, Kadomatsu K, Muramatsu T, Noda M (1999) A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta. J Biol Chem 274:12474-12479
99. Manabe R, Kovalenko M,Webb DJ, Horwitz AR (2002) GIT1 functions in a motile, multi-molecular signaling complex that regulates protrusive activity and cell migration. J Cell Sci 115:1497-1510
100. Marchionini DM, Lehrmann E, Chu Y, He B, Sortwell CE, Becker KG, Freed WJ, Kordower JH, Collier TJ (2007) Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease. Brain Res 1147:77-88
101. Maurel P, Rauch U, Flad M, Margolis RK, Margolis RU (1994) Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase. Proc Natl Acad Sci U S A 91:2512-2516
102. Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, Noda M, Deuel TF (2000) Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci U S A 97:2603-2608
103. Mooney RA, LeVea CM (2003) The leukocyte common antigenrelated protein LAR: candidate PTP for inhibitory targeting. Curr Top Med Chem 3:809-819
104. Moses HL, Yang EY, Pietenpol JA (1990) TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247
105. Muller T, Choidas A, Reichmann E, Ullrich A (1999) Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J Biol Chem 274:10173-10183
106. Munoz JJ, Tarrega C, Blanco-Aparicio C, Pulido R (2003) Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. Biochem J 372:193-201
107. Mustelin T, Tasken K (2003) Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J 371:15-27
108. Mustelin T, Feng GS, Bottini N, Alonso A, Kholod N, Birle D, Merlo J, Huynh H (2002) Protein tyrosine phosphatases. Front Biosci 7: d85-d142
109. Nakamura M, Kishi M, Sakaki T, Hashimoto H, Nakase H, Shimada K, Ishida E, Konishi N (2003) Novel tumor suppressor loci on 6q22- 23 in primary central nervous system lymphomas. Cancer Res 63:737-741
110. Nakamura F, Nakamura Y, Maki K, Sato Y, Mitani K (2005) Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13). Cancer Res 65:6612-6621
111. Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, Bui TN, Baum LG (2001) CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J Immunol 167:5697-5707
112. Notkins AL (2002) Immunologic and genetic factors in type 1 diabetes. J Biol Chem 277:43545-43548
113. Novellino L, Renkvist N, Rini F, Mazzocchi A, Rivoltini L, Greco A, Deho P, Squarcina P, Robbins PF, Parmiani G et al (2003) Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen. J Immunol 170:6363-6370
114. O'Grady P, Thai TC, Saito H (1998) The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase LAR. J Cell Biol 141:1675-1684
115. Ostman A, Yang Q, Tonks NK (1994) Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci U S A 91:9680-9684
116. Ostman A, Hellberg C, Bohmer FD (2006) Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 6:307-320
117. Padilla PI, Wada A, Yahiro K, Kimura M, Niidome T, Aoyagi H, Kumatori A, Anami M, Hayashi T, Fujisawa J et al (2000) Morphologic differentiation of HL-60 cells is associated with appearance of RPTPbeta and induction of Helicobacter pylori VacA sensitivity. J Biol Chem 275:15200-15206
118. Palka HL, Park M, Tonks NK (2003) Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor proteintyrosine phosphatase DEP-1. J Biol Chem 278:5728-5735
119. Pariser H, Ezquerra L, Herradon G, Perez-Pinera P, Deuel TF (2005a) Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin. Biochem Biophys Res Commun 332:664-669
120. Pariser H, Perez-Pinera P, Ezquerra L, Herradon G, Deuel TF (2005b) Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta. Biochem Biophys Res Commun 335:232-239
121. Peles E, Nativ M, Campbell PL, Sakurai T, Martinez R, Lev S, Clary DO, Schilling J, Barnea G, Plowman GD et al (1995) The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell 82:251-260
122. Peles E, Schlessinger J, Grumet M (1998) Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling. Trends Biochem Sci 23:121-124
123. Pera IL, Iuliano R, Florio T, Susini C, Trapasso F, Santoro M, Chiariotti L, Schettini G, Viglietto G, Fusco A (2005) The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene 24:3187-3195
124. Perez-Pinera P, Zhang W, Chang Y, Vega JA, Deuel TF (2007) Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation. J Biol Chem 282:28683-28690
125. Persson C, Sjoblom T, Groen A, Kappert K, Engstrom U, Hellman U, Heldin CH, den Hertog J, Ostman A (2004) Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci U S A 101:1886-1891
126. Ponniah S,Wang DZ, Lim KL, Pallen CJ (1999) Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr Biol 9:535-538
127. Pulido R, Zuniga A, Ullrich A (1998) PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J 17:7337-7350
128. Qiao S, Iwashita T, Furukawa T, Yamamoto M, Sobue G, Takahashi M (2001) Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins. J Biol Chem 276:9460-9467
129. Ruivenkamp CA, vanWezel T, Zanon C, Stassen AP, Vlcek C, Csikos T, Klous AM, Tripodis N, Perrakis A, Boerrigter L et al (2002) Ptprj is a candidate for themouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 31:295-300
130. Sacco F, TintiM, Palma A, Ferrari E, Nardozza AP,Hooft van Huijsduijnen R, Takahashi T, Castagnoli L, Cesareni G (2009) Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases. J Biol Chem 284:22048-22058
131. Saeki K, Zhu M, Kubosaki A, Xie J, Lan MS, Notkins AL (2002) Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion. Diabetes 51:1842-1850
132. Saito H (1993) Structural diversity of eukaryotic protein tyrosine phosphatases: functional and evolutionary implications. Semin Cell Biol 4:379-387
133. Sap J, Jiang YP, Friedlander D, Grumet M, Schlessinger J (1994) Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding. Mol Cell Biol 14:1-9
134. Sato T, Nunomura S, Sato C, Hozumi K, Kumagai Y, Nishimura T, Mak TW, Kishihara K, Habu S (1999) CD45 can act as a negative regulator for the transition from early to late CD4+ CD8+ thymocytes. Int Immunol 11:89-97
135. Schaapveld RQ, Schepens JT, Robinson GW, Attema J, Oerlemans FT, Fransen JA, Streuli M, Wieringa B, Hennighausen L, Hendriks WJ (1997) Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Dev Biol 188:134-146
136. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103:211-225
137. Serra-Pages C, Saito H, Streuli M (1994) Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase. J Biol Chem 269:23632-23641
138. Serra-Pages C, Kedersha NL, Fazikas L, Medley Q, Debant A, Streuli M (1995) The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions. EMBO J 14:2827-2838
139. Sherwin JR, Sharkey AM, Mihalyi A, Simsa P, Catalano RD, D'Hooghe TM (2008) Global gene analysis of late secretory phase, eutopic endometrium does not provide the basis for a minimally invasive test of endometriosis. Hum Reprod 23:1063-1068
140. Shintani T, Noda M (2008) Protein tyrosine phosphatase receptor type Z dephosphorylates TrkA receptors and attenuates NGFdependent neurite outgrowth of PC12 cells. J Biochem 144:259-266
141. Solimena M, Dirkx R Jr, Hermel JM, Pleasic-Williams S, Shapiro JA, Caron L, Rabin DU (1996) ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 15:2102-2114
142. Sorby M, Sandstrom J, Ostman A (2001) An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1. Oncogene 20:5219-5224
143. Spertini F, Wang AV, Chatila T, Geha RS (1994) Engagement of the common leukocyte antigen CD45 induces homotypic adhesion of activated human T cells. J Immunol 153:1593-1602
144. Stanton T, Boxall S, Hirai K, Dawes R, Tonks S, Yasui T, Kanaoka Y, Yuldasheva N, Ishiko O, BodmerWet al (2003) A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression. Proc Natl Acad Sci U S A 100:5997-6002
145. Stover DR, Charbonneau H, Tonks NK, Walsh KA (1991) Proteintyrosine- phosphatase CD45 is phosphorylated transiently on tyrosine upon activation of Jurkat T cells. Proc Natl Acad Sci U S A 88:7704-7707
146. Streuli M, Krueger NX, Hall LR, Schlossman SF, Saito H (1988) A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. J Exp Med 168:1523-1530
147. Streuli M, Krueger NX, Thai T, Tang M, Saito H (1990) Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J 9:2399-2407
148. Streuli M, Krueger NX, Ariniello PD, Tang M, Munro JM, Blattler WA, Adler DA, Disteche CM, Saito H (1992) Expression of the receptor-linked protein tyrosine phosphatase LAR: proteolytic cleavage and shedding of the CAM-like extracellular region. EMBO J 11:897-907
149. Su J, Batzer A, Sap J (1994) Receptor tyrosine phosphatase R-PTPalpha is tyrosine-phosphorylated and associated with the adaptor protein Grb2. J Biol Chem 269:18731-18734
150. Su J, Yang LT, Sap J (1996) Association between receptor proteintyrosine phosphatase RPTPalpha and the Grb2 adaptor. Dual Src homology (SH) 2/SH3 domain requirement and functional consequences. J Biol Chem 271:28086-28096
151. Su J, Muranjan M, Sap J (1999) Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr Biol 9:505-511
152. Suarez Pestana E, Tenev T, Gross S, Stoyanov B, Ogata M, Bohmer FD (1999) The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells. Oncogene 18:4069-4079
153. Takahashi T, Takahashi K, St John PL, Fleming PA, Tomemori T, Watanabe T, Abrahamson DR, Drake CJ, Shirasawa T, Daniel TO (2003) A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol Cell Biol 23:1817- 1831
154. Takahashi T, Takahashi K, Mernaugh RL, Tsuboi N, Liu H, Daniel TO (2006) A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis. Blood 108:1234-1242
155. Tamura H, Fukada M, Fujikawa A, Noda M (2006) Protein tyrosine phosphatase receptor type Z is involved in hippocampusdependent memory formation through dephosphorylation at Y1105 on p190 RhoGAP. Neurosci Lett 399:33-38
156. Tan X, Stover DR,Walsh KA (1993) Demonstration of protein tyrosine phosphatase activity in the second of two homologous domains of CD45. J Biol Chem 268:6835-6838
157. Tchilian EZ, Beverley PC (2006) Altered CD45 expression and disease. Trends Immunol 27:146-153
158. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC (2001) A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 166:1308-1313
159. Thalmeier A, Dickmann M, Giegling I, Schneider B, M Hartmann A, Maurer K, Schnabel A, Kauert G, Moller HJ, Rujescu D (2008) Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. Int J Neuropsychopharmacol 11:217-228
160. Thomas ML, Brown EJ (1999) Positive and negative regulation of Srcfamily membrane kinases by CD45. Immunol Today 20:406-411
161. Thomas ML, Lefrancois L (1988) Differential expression of the leucocyte-common antigen family. Immunol Today 9:320-326
162. Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7:833-846
163. Tonks NK, Neel BG (1996) From form to function: signaling by protein tyrosine phosphatases. Cell 87:365-368
164. Tonks NK, Charbonneau H, Diltz CD, Fischer EH, Walsh KA (1988) Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemistry 27:8695-8701
165. Tracy S, van der Geer P, Hunter T (1995) The receptor-like proteintyrosine phosphatase, RPTP alpha, is phosphorylated by protein kinase C on two serines close to the inner face of the plasma membrane. J Biol Chem 270:10587-10594
166. Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G, Fusco A (2000) Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype ofretrovirally transformed thyroid cells through the stabilization of p27 (Kip1). Mol Cell Biol 20:9236-9246
167. Tsai W, Morielli AD, Cachero TG, Peralta EG (1999) Receptor protein tyrosine phosphatase alpha participates in the m1 muscarinic acetylcholine receptor-dependent regulation of Kv1.2 channel activity. EMBO J 18:109-118
168. Tsuboi N, Utsunomiya T, Roberts RL, Ito H, Takahashi K, Noda M, Takahashi T (2008) The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J 413:193-200
169. Tsujikawa K, Kawakami N, Uchino Y, Ichijo T, Furukawa T, Saito H, Yamamoto H (2001) Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigenrelated) on tyrosine dephosphorylation of insulin receptor. Mol Endocrinol 15:271-280
170. Tsujikawa K, Ichijo T, Moriyama K, Tadotsu N, Sakamoto K, Sakane N, Fukada S, Furukawa T, Saito H, Yamamoto H (2002) Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule. Mol Cancer Res 1:155-163
171. van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H (2003) Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423:773-777
172. von Wichert G, Jiang G, Kostic A, De Vos K, Sap J, Sheetz MP (2003) RPTP-alpha acts as a transducer of mechanical force on alphav/beta3-integrin- cytoskeleton linkages. J Cell Biol 161:143-153
173. Walton KM, Dixon JE (1993) Protein tyrosine phosphatases. Annu Rev Biochem 62:101-120
174. Walzel H, Schulz U, Neels P, Brock J (1999) Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. Immunol Lett 67:193-202
175. Wang Y, Pallen CJ (1991) The receptor-like protein tyrosine phosphatase HPTP alpha has two active catalytic domains with distinct substrate specificities. EMBO J 10:3231-3237
176. Wang Y, Guo W, Liang L, Esselman WJ (1999) Phosphorylation of CD45 by casein kinase 2. Modulation of activity and mutational analysis. J Biol Chem 274:7454-7461
177. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S, Ptak J, Silliman N, Peters BA, van der Heijden MS et al (2004) Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304:1164-1166
178. Wang SE, Wu FY, Shin I, Qu S, Arteaga CL (2005) Transforming growth factor beta (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function. Mol Cell Biol 25:4703-4715
179. Weng LP, Wang X, Yu Q (1999) Transmembrane tyrosine phosphatase LAR induces apoptosis by dephosphorylating and destabilizing p130Cas. Genes Cells 4:185-196
180. Xu Y, Tan LJ, Grachtchouk V, Voorhees JJ, Fisher GJ (2005) Receptortype protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function. J Biol Chem 280:42694-42700
181. Xu Y, Shao Y, Voorhees JJ, Fisher GJ (2006) Oxidative inhibition of receptor-type protein-tyrosine phosphatase kappa by ultraviolet irradiation activates epidermal growth factor receptor in human keratinocytes. J Biol Chem 281:27389-27397
182. Xu Y, Baker D, Quan T, Baldassare JJ, Voorhees JJ, Fisher GJ (2010) Receptor type protein tyrosine phosphatase-kappa mediates crosstalk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes. Mol Biol Cell 21:29-35
183. Yahiro K, Niidome T, Kimura M, Hatakeyama T, Aoyagi H, Kurazono H, Imagawa K, Wada A, Moss J, Hirayama T (1999) Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. J Biol Chem 274:36693-36699
184. Yahiro K, Wada A, Nakayama M, Kimura T, Ogushi K, Niidome T, Aoyagi H, Yoshino K, Yonezawa K, Moss J et al (2003) Proteintyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J Biol Chem 278:19183-19189
185. Yang T, Zhang JS, Massa SM, Han X, Longo FM (1999) Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue. Mol Carcinog 25:139-149
186. Yang T, Bernabeu R, Xie Y, Zhang JS, Massa SM, Rempel HC, Longo FM (2003) Leukocyte antigen-related protein tyrosine phosphatase receptor: a small ectodomain isoform functions as a homophilic ligand and promotes neurite outgrowth. J Neurosci 23:3353-3363
187. Yeo TT, Yang T, Massa SM, Zhang JS, Honkaniemi J, Butcher LL, Longo FM (1997) Deficient LAR expression decreases basal forebrain cholinergic neuronal size and hippocampal cholinergic innervation. J Neurosci Res 47:348-360
188. Zabolotny JM, Kim YB, Peroni OD, Kim JK, Pani MA, Boss O, Klaman LD, Kamatkar S, Shulman GI, Kahn BB et al (2001) Overexpression of the LAR (leukocyte antigen-related) proteintyrosine phosphatase in muscle causes insulin resistance. Proc Natl Acad Sci U S A 98:5187-5192
189. Zeng L, D'Alessandri L, Kalousek MB, Vaughan L, Pallen CJ (1999) Protein tyrosine phosphatase alpha (PTPalpha) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn. J Cell Biol 147:707-714
190. Zhang L, Martelli ML, Battaglia C, Trapasso F, Tramontano D, Viglietto G, Porcellini A, Santoro M, Fusco A (1997) Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. Exp Cell Res 235:62-70
191. Zhang M, Moran M, Round J, Low TA, Patel VP, Tomassian T, Hernandez JD, Miceli MC (2005) CD45 signals outside of lipid rafts to promote ERK activation, synaptic raft clustering, and IL-2 production. J Immunol 174:1479-1490
192. Zheng XM, Wang Y, Pallen CJ (1992) Cell transformation and activation of pp 60c-src by overexpression of a protein tyrosine phosphatase. Nature 359:336-339
193. Zheng XM, Resnick RJ, Shalloway D (2000) A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO J 19:964-978
194. Zondag GC, Koningstein GM, Jiang YP, Sap J, Moolenaar WH, Gebbink MF (1995) Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain. J Biol Chem 270:14247- 14250
195. Zuniga A, Torres J, Ubeda J, Pulido R (1999) Interaction of mitogenactivated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. J Biol Chem 274:21900-21907